Shanghai Pharmaceuticals
Scope
Date
~
-
Bio & Pharma
SK Biopharm begins clinical trials of wearable device for detecting epilepsy
SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong submits new drug applications for Fexuclue in 10 countries
South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean Proteina gets offers from global pharmaceutical companies
Global pharmaceutical companies are expressing keen interest in the South Korean diagnostics company Proteina. Unlike companies that search for sp...
Dec 12, 2022 (Gmt+09:00)
-
Bio & Pharma
Boryung holds Care-in-Space Challenge in US for space healthcare startups
South Korea's pharmaceutical company Boryeong said on Friday that it held the first "Care-in-Space Challenge" event, a new space healthcare startup ...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea approves Daewoong Pharmaceutical's diabetes drug
DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight ye...
Dec 02, 2022 (Gmt+09:00)
-
Food & Beverage
Daesang Welllife forms joint venture with Sinopharm Group
Daesang Welllife on Thursday said it has concluded a memorandum of understanding (MOU) with China Sinopharm International, an affiliate of China's l...
Dec 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharmaceutical relocates US research center from Seattle to Boston
JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...
Nov 23, 2022 (Gmt+09:00)
-
Batteries
LG Energy surrenders No. 2 EV battery position to BYD
LG Energy Solution Ltd., South Korea’s leading battery maker, gave up its second-largest position in the global electric vehicle cell market...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
SK's biotech bets step closer to commercialization
Biotechnology startups in Europe, backed by South Korea's SK Inc., are speeding up their development of next-generation drug candidates by joining h...
Apr 15, 2022 (Gmt+09:00)
-
COVID-19
Korea firms’ Shanghai plants to remain disrupted long on lockdown
South Korean companies’ production in Shanghai is expected to remain disrupted long on the lockdown to curb the spread of COVID-19, raising co...
Apr 15, 2022 (Gmt+09:00)
language -
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
Alternative investments
E-Land sells Shanghai warehouse for $2.2 bn to lower debt ratio
Retail conglomerate E-Land Group completed selling its first overseas logistics center in Shanghai for about 1.4 billion Chinese yuan ($2.2 billion)...
Jan 12, 2022 (Gmt+09:00)
language -
Bio
K-bio's out-licensing this year reaches $9.3 bn
Overseas technology transfers from South Korean biotechs and pharmaceutical manufacturers this year have exceeded 11 trillion won ($9.3 billion), al...
Nov 18, 2021 (Gmt+09:00)
language -
Biotech
Korea’s bio startup Voronoi inks $324 million deal with Brickell Biotech
Voronoi Inc., a South Korean biotechnology startup, has clinched a $324 million deal to grant Brickell Biotech, a US clinical-stage pharmaceutical f...
Sep 02, 2021 (Gmt+09:00)
language -
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language -
Electric vehicles
Hyundai debuts First Genesis EV sedan at Shanghai Auto Show
Hyundai Motor Co. on Monday unveiled an electric version of its premium brand Genesis at the opening of Auto Shanghai 2021 as the top South Korean c...
Apr 19, 2021 (Gmt+09:00)
language
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand